ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 48 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $751,138 | +143.5% | 18,949 | +17.1% | 0.00% | +200.0% |
| Q4 2023 | $308,486 | +70.1% | 16,185 | +2.2% | 0.00% | 0.0% |
| Q3 2023 | $181,391 | +15.5% | 15,842 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $157,068 | +78.2% | 15,279 | +33.8% | 0.00% | 0.0% |
| Q1 2023 | $88,147 | +12.0% | 11,418 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $78,719 | +48.5% | 10,710 | +44.4% | 0.00% | – |
| Q3 2022 | $53,000 | -14.5% | 7,415 | +1.4% | 0.00% | – |
| Q2 2022 | $62,000 | +19.2% | 7,310 | +26.8% | 0.00% | – |
| Q1 2022 | $52,000 | -38.8% | 5,767 | -6.6% | 0.00% | – |
| Q4 2021 | $85,000 | +25.0% | 6,173 | -2.9% | 0.00% | – |
| Q3 2021 | $68,000 | +15.3% | 6,358 | -2.3% | 0.00% | – |
| Q2 2021 | $59,000 | – | 6,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|